Aquestive Therapeutics (AQST) Net Margin Growth (5y) (2022 - 2026)
Aquestive Therapeutics (AQST) Net Margin Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Aquestive Therapeutics | 583.72 Mn | 583.72 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45,290.00 |
| Mar 31, 2026 | 12,763.00 |
| Dec 31, 2025 | 35,874.00 |
| Sep 30, 2025 | 8,628.00 |
| Jun 30, 2025 | -10,626.00 |
| Mar 31, 2025 | -7,437.00 |
| Dec 31, 2024 | -6,676.00 |
| Sep 30, 2024 | 6,328.00 |
| Jun 30, 2024 | 17,029.00 |
| Mar 31, 2024 | 1,005.00 |
| Dec 31, 2023 | 2,146.00 |
| Sep 30, 2023 | 9,770.00 |
| Jun 30, 2023 | 21,827.00 |
| Mar 31, 2023 | 5,495.00 |
| Dec 31, 2022 | -2,816.00 |
| Sep 30, 2022 | -13,819.00 |
| Jun 30, 2022 | -14,533.00 |